NOVORIG
Rapid Novor Inc.
Trademark Registered: 2022-10-04
Trademark Application Details
SUSPENSION INQUIRY - MAILED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 90977298 |
| Registration Number | 6863141 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Domestic Representative | Jeffrey B. Sladkus, Esq. |
| Attorney Name | Jeffrey B. Sladkus, Esq. |
| Law Office Assigned | N20 |
| Employee Name | CUMMINS, LANCE E |
Timeline
| 2020-08-13 | Application Filed |
| 2021-11-05 | Status: Live/Pending |
| 2022-05-31 | Location: DIVISIONAL UNIT |
| 2022-05-31 | Transaction Date |
| 2022-10-04 | Trademark Registered |
Trademark Applicants & Owners
| Owner: |  Rapid Novor Inc. |
| Address | 137 Glasgow St., Unit 450 Kitchener, Ontario CA N2G4X8 |
| Legal Entity Type | Corporation |
| Legal Entity State | CA |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0421 | Development of new technology for others in the field of biotechnology; Proteomics analysis services for scientific research purposes; Antibody profiling for scientific research purposes; Laboratory research in the field of immune sequencing; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research in the field of immune sequencing; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals; Medical research and medical research analysis in the field of medicine; Research and development in the pharmaceutical and biotechnology fields; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Medical laboratory services |
| GS0421 | Development of new technology for others in the field of biotechnology; Proteomics analysis services for scientific research purposes; Antibody profiling for scientific research purposes; Laboratory research in the field of immune sequencing; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research in the field of immune sequencing; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals; Medical research and medical research analysis in the field of medicine; Research and development in the pharmaceutical and biotechnology fields; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Medical laboratory services |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2020-09-17 | 1 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2020-12-08 | 2 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2020-12-08 | 3 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2020-12-08 | 4 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2020-12-08 | 5 GNRN O:Outgoing Correspondence |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2020-12-14 | 6 COAR I:Incoming Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2020-12-14 | 7 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2020-12-14 | 8 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | 2020-12-14 | 9 ECDR I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2020-12-14 | 10 TCCA I:Incoming Correspondence |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2020-12-14 | 11 CHAN I:Incoming Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2020-12-16 | 12 TROA I:Incoming Correspondence |
| ASSIGNED TO LIE | 2021-03-18 | 13 ALIE A:Allowance for Publication |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2021-03-23 | 14 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2021-03-23 | 15 TEME I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2021-04-12 | 16 DOCK D:Assigned to Examiner |
| SUSPENSION LETTER WRITTEN | 2021-05-05 | 17 CNSL R:Renewal |
| LETTER OF SUSPENSION E-MAILED | 2021-05-05 | 18 GNSL S: |
| NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | 2021-05-05 | 19 GNS3 O:Outgoing Correspondence |
| SUSPENSION INQUIRY WRITTEN | 2021-11-05 | 20 CNSI R:Renewal |
| INQUIRY TO SUSPENSION E-MAILED | 2021-11-05 | 21 GNSI S: |
| NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | 2021-11-05 | 22 GNS2 O:Outgoing Correspondence |
| TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | 2022-05-03 | 23 ERSI I:Incoming Correspondence |
| TEAS AMENDMENT OF USE RECEIVED | 2022-05-03 | 24 EAAU I:Incoming Correspondence |
| TEAS REQUEST TO DIVIDE RECEIVED | 2022-05-03 | 25 ERTD I:Incoming Correspondence |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2022-05-31 | 26 AITU A:Allowance for Publication |
| DIVISIONAL REQUEST RECEIVED | 2022-05-03 | 27 DRRR I:Incoming Correspondence |
| DIVISIONAL PROCESSING COMPLETE | 2022-05-31 | 28 DPCC D:Assigned to Examiner |
| USE AMENDMENT FILED | 2022-05-03 | 29 IUAF S: |
| AMENDMENT TO USE PROCESSING COMPLETE | 2022-05-03 | 30 AUPC I:Incoming Correspondence |
| USE AMENDMENT ACCEPTED | 2022-06-01 | 31 IUAA P: |
| SUSPENSION LETTER WRITTEN | 2022-06-01 | 32 CNSL R:Renewal |
| LETTER OF SUSPENSION E-MAILED | 2022-06-01 | 33 GNSL S: |
| NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | 2022-06-01 | 34 GNS3 O:Outgoing Correspondence |
| NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED | 2022-06-02 | 35 AAUA E:E-Mail |
| TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | 2022-06-13 | 36 ERSI I:Incoming Correspondence |
| ASSIGNED TO LIE | 2022-06-15 | 37 ALIE A:Allowance for Publication |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2022-06-16 | 38 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2022-06-16 | 39 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2022-06-16 | 40 CNSA O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2022-06-29 | 41 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2022-07-19 | 42 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2022-07-19 | 43 NPUB E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2022-10-04 | 44 R.PR A:Allowance for Publication |
| NOTICE OF REGISTRATION CONFIRMATION EMAILED | 2022-10-04 | 45 NRCC E:E-Mail |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 NOVORIG 90977298 not registered Live/Pending |
Rapid Novor Inc. 2020-08-13 |
 NOVORIG 90112581 not registered Live/Pending |
Rapid Novor Inc. 2020-08-13 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 